Frame 1000003625
Frame 1000003626

AI-guided life sciences intelligence for better BD&L decisions

AI-Guided Search Workflow From natural language query to structured BD&L output
ai flowchart
ai flowchart tablet
ai flowchart mobile

See the platform in action

Watch a short walkthrough of Biotechgate's AI-guided search workflows.

Watch video

Identify licensing opportunities, qualified partners, investment prospects and competitive signals with less manual research. Search structured, sourced life sciences data, human-curated research content and AI-guided workflows. All in one intelligence platform.

Some of our clients

Our Platform

Two AI-guided workflows.
One life sciences intelligence platform.

Biotechgate combines deep life sciences data with AI-guided search and research workflows. Whether you're identifying licensing opportunities or conducting due diligence, you get to the insight that matters without spending hours piecing information together.

BD&L Intelligence

Search in plain language across companies, assets, licensing opportunities, deals, trials, financing rounds, management contacts and partnering interests. Just describe what you're looking for and Biotechgate translates it into precise, structured results. No complex query language. No dead ends.

Explore BD&L Intelligence

AI Research Workspace

Ask questions across curated analyst reports and financial models to support due diligence, valuation, pipeline assessment and market research. Get sourced insights from trusted research content, so your team can spend less time reviewing documents and more time deciding what matters.

Explore AI Research Workspace
Our Coverage

Structured data and
research intelligence behind every AI-guided workflow.

Biotechgate's intelligence layer connects curated company, asset, clinical, financial, deal and contact data - giving your team the structured foundation needed for faster search, analysis and business development decisions.

70K+

Company Profiles

Global life sciences companies with structured business and pipeline data.

385K+

Management Contacts

Executive and functional contacts for outreach, qualification and partnering.

42K+

Licensing-ready Assets

Assets and technologies with development phase, indication and licensing status.

1M+

Clinical Trials

Trial activity to support pipeline, competitor and market analysis.

250K+

Reports & Forecast Models

Curated analyst reports and financial models for research, valuation and due diligence.

48K+

License Agreements

Deal terms, territories, payment structures and original contract references.

Curated, continuously updated life science intelligence - combining structured data, expert review and source-based research content.

baner overview

Aug 31 – Sep 4, 2026

Free registration

BIOTECHGATE DIGITAL PARTNERING

Virtual business development & licensing event

Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.

What our clients say

“Since I started to use Biotechgate my prospective activities have become far less time-consuming and the collected information much more up-to-date which is most satisfactory.”

Linda Slipko

Business Development Manager at GreenLight Clinical

We have used Biotechgate for a year now and we have been very satisfied with the system so far. It has provided us with an enormous amount of business intelligence of our marketplace.

Chris Huiskamp

Managing Partner at Sourcia

Liftstream was compelled to subscribe to Biotechgate as it is really the only international database of the life sciences sector which is frequently updated by those who are listed on it. This ensures that you can access and retrieve information based on geography, therapy, modality, management or any other category of information which is important to your search.

Karl Simpson

CEO at Liftstream

Upcoming Conferences

 

20 October 2026
20 October 2026

AusBiotech Invest

Queensland, Australia
AusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences. More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
21 October 2026
23 October 2026

AusBiotech International Conference

Queensland, Australia
The AusBiotech International Conference is Australia’s largest biotechnology conference and part of Australia’s Biggest Week in Biotech, connecting local expertise with Australian and international partners to accelerate innovation and impact. Join us at the Gold Coast Convention & Exhibition Centre, Queensland, from 21 to 23 October, 2026. This October, AusBiotech International Conference will be presented alongside the AusMedtech Conference, connecting local expertise with Australian and international partners to accelerate innovation and impact. Your International Conference registration will include access to all AusMedtech events.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
27 October 2026
28 October 2026

BioFuture 2026

New York City, USA
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more
04 November 2026
04 November 2026

Drug Discovery Innovators & Investors: London, UK

London, United Kingdom
Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.
Read more

See how Biotechgate can enhance
your business development